Make COSELA commercially available
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 16 Feb 2021
- Due
- 31 Mar 2021
- Delivered
- 2 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“COSELA is expected to be commercially available through G1’s specialty distributor partner network in early March.”
What we found
Evidence strength A What the grades mean
G1 Therapeutics made COSELA commercially available through its specialty distributor network on March 2, 2021, meeting the commitment to launch in early March.
-
A G1 Therapeutics, Inc. 10-Q filed 2021-05-05
“On March 2, 2021, COSELA became commercially available through G1’s specialty distributor network.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- COSELA
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you G1 Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C560241-023833 · Corrections policy